Metabolic Positron Emission Tomography Imaging in Cancer Detection and Therapy Response
- 31 January 2011
- journal article
- review article
- Published by Elsevier BV in Seminars in Oncology
- Vol. 38 (1), 55-69
- https://doi.org/10.1053/j.seminoncol.2010.11.012
Abstract
No abstract availableThis publication has 113 references indexed in Scilit:
- Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Meta-analysis of the performance of 18F-FDG PET in cutaneous melanomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Clinical Applications of FDG PET and PET/CT in Head and Neck CancerJournal of Oncology, 2009
- Optimization of automated large-scale production of [18F]fluoroethylcholine for PET prostate cancer imagingNuclear Medicine and Biology, 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal CancerJournal of Nuclear Medicine, 2009
- The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancerEuropean Radiology, 2009
- Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancerBMC Cancer, 2008
- Radiolabeled choline as a proliferation marker: Comparison with radiolabeled acetateNuclear Medicine and Biology, 2004
- Fluorinated tracers for imaging cancer with positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004